Delivery Order SPE2DR25D7909-SPE2DR26FX7DT
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $12.5K delivery order on December 1, 2025, for the supply of Procainamide 1 gram/10 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,512.96 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on a firm fixed-price basis. The award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-competitive delivery order under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,137.63. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,352.76 to AmerisourceBergen Drug Corp for the supply of Procainamide 1,000 mg/2 mL vials. This contract, which was competitively awarded without set-aside provisions, carries a firm fixed price and an ultimate completion date of August 4, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 vehicle...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,505.03. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $7,465.68. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,791.77 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials. This is a firm fixed price delivery order with an ultimate completion date of December 18, 2025, and represents a non-competitive set-aside procurement. The award is performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains operations as a major pharmaceutical distributor...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Procainamide 1 gram/10 mL vials. This firm fixed-price delivery order, valued at $6,447.79, is scheduled for completion by August 4, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 20, 2025, with completion scheduled for November 21, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- SPE2DR25D7909Indefinite Delivery Contract
- SPE2DR25D7909-SPE2DR26FX7DTDelivery Order
The Defense Logistics Agency awarded a $5,005.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on December 23, 2025, with an ultimate completion date of December 24, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a total potential value of $999,999,999 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its comprehensive federal contract portfolio with the Defense Logistics Agency. The company's SPE2DX IDC functions as a global pharmaceutical support vehicle enabling the supply of an extensive range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Procainamide, an antiarrhythmic medication used in cardiac care, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for Defense Health Agency and other federal healthcare customers through the flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/22/25 |